169 related articles for article (PubMed ID: 6648004)
1. Hyperthermic perfusion in malignant melanoma: 5-year results.
Tonak J; Hohenberger W; Weidner F; Göhl H
Recent Results Cancer Res; 1983; 86():229-38. PubMed ID: 6648004
[TBL] [Abstract][Full Text] [Related]
2. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
Jönsson PE; Hafström L; Hugander A
Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
[No Abstract] [Full Text] [Related]
3. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan.
Lejeune FJ; Deloof T; Ewalenko P; Fruhling J; Jabri M; Mathieu M; Nogaret JM; Verhest A
Recent Results Cancer Res; 1983; 86():268-76. PubMed ID: 6648008
[No Abstract] [Full Text] [Related]
4. Hyperthermic perfusion with chemotherapy for melanoma of the extremities.
Ghussen F; Krüger I; Smalley RV; Groth W
World J Surg; 1989; 13(5):598-602. PubMed ID: 2815804
[TBL] [Abstract][Full Text] [Related]
5. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
Olofsson Bagge R; Mattsson J; Hafström L
Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic regional perfusion in high-risk stage-I malignant melanomas of the extremities.
Koops HS; Oldhoff J
Recent Results Cancer Res; 1983; 86():223-8. PubMed ID: 6648003
[TBL] [Abstract][Full Text] [Related]
7. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
Ghussen F; Krüger I; Groth W; Stützer H
Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
[TBL] [Abstract][Full Text] [Related]
8. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
10. Results of hyperthermic perfusion for melanoma of the extremities.
Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents.
Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis WJ; van der Weele LT
Cancer; 1989 Jan; 63(1):199-203. PubMed ID: 2910418
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic isolation limb perfusion for malignant melanoma: a review.
Coit DG
Cancer Invest; 1992; 10(4):277-84. PubMed ID: 1628227
[No Abstract] [Full Text] [Related]
13. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
Hafström L
Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
[No Abstract] [Full Text] [Related]
14. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.
Hafström L; Rudenstam CM; Blomquist E; Ingvar C; Jönsson PE; Lagerlöf B; Lindholm C; Ringborg U; Westman G; Ostrup L
J Clin Oncol; 1991 Dec; 9(12):2091-4. PubMed ID: 1960549
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanoma.
Lejeune FJ; Mathieu M; Kenis Y
Tumori; 1977; 63(3):289-98. PubMed ID: 898296
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.
Bryant PJ; Balderson GA; Mead P; Egerton WS
World J Surg; 1995; 19(3):363-8. PubMed ID: 7638989
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic adjuvant perfusion chemotherapy for Stage I malignant melanoma of the extremity with literature review.
Rege VB; Leone LA; Soderberg CH; Coleman GV; Robidoux HJ; Fijman R; Brown J
Cancer; 1983 Dec; 52(11):2033-9. PubMed ID: 6354421
[TBL] [Abstract][Full Text] [Related]
19. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
Thompson JF; Gianoutsos MP
World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
[TBL] [Abstract][Full Text] [Related]
20. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
